Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
Maeda Y, Kobashi K, Sato Y, Tamamura H, Yamamoto K, Matsushita K, Sasaki M, Tatebe H, Asahi T, Matsumoto S, Takamatsu S, Miyazaki K, Fujimoto R, Uchinami Y, Katoh N, Aoyama H. Maeda Y, et al. Among authors: kobashi k. Med Phys. 2023 Jun;50(6):3274-3288. doi: 10.1002/mp.16433. Epub 2023 Apr 26. Med Phys. 2023. PMID: 37099416
Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients.
Yasuda K, Minatogawa H, Dekura Y, Takao S, Tamura M, Tsushima N, Suzuki T, Kano S, Mizumachi T, Mori T, Nishioka K, Shido M, Katoh N, Taguchi H, Fujima N, Onimaru R, Yokota I, Kobashi K, Shimizu S, Homma A, Shirato H, Aoyama H. Yasuda K, et al. Among authors: kobashi k. J Radiat Res. 2021 Mar 10;62(2):329-337. doi: 10.1093/jrr/rraa130. J Radiat Res. 2021. PMID: 33372202 Free PMC article.
A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer.
Yoshimura T, Nishioka K, Hashimoto T, Seki K, Kogame S, Tanaka S, Kanehira T, Tamura M, Takao S, Matsuura T, Kobashi K, Kato F, Aoyama H, Shimizu S. Yoshimura T, et al. Among authors: kobashi k. Phys Imaging Radiat Oncol. 2021 Oct 8;20:23-29. doi: 10.1016/j.phro.2021.09.006. eCollection 2021 Oct. Phys Imaging Radiat Oncol. 2021. PMID: 34693040 Free PMC article.
Dosimetric advantages of daily adaptive strategy in IMPT for high-risk prostate cancer.
Tamura H, Kobashi K, Nishioka K, Yoshimura T, Hashimoto T, Shimizu S, Ito YM, Maeda Y, Sasaki M, Yamamoto K, Tamamura H, Aoyama H, Shirato H. Tamura H, et al. Among authors: kobashi k. J Appl Clin Med Phys. 2022 Apr;23(4):e13531. doi: 10.1002/acm2.13531. Epub 2022 Jan 19. J Appl Clin Med Phys. 2022. PMID: 35045211 Free PMC article.
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity.
Uchinami Y, Katoh N, Suzuki R, Kanehira T, Tamura M, Takao S, Matsuura T, Miyamoto N, Fujita Y, Koizumi F, Taguchi H, Yasuda K, Nishioka K, Yokota I, Kobashi K, Aoyama H. Uchinami Y, et al. Among authors: kobashi k. Clin Transl Radiat Oncol. 2022 May 17;35:70-75. doi: 10.1016/j.ctro.2022.05.004. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35633653 Free PMC article.
Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
Uchinami Y, Katoh N, Abo D, Morita R, Taguchi H, Fujita Y, Kanehira T, Suzuki R, Miyamoto N, Takao S, Matsuura T, Sho T, Ogawa K, Orimo T, Kakisaka T, Kobashi K, Aoyama H. Uchinami Y, et al. Among authors: kobashi k. Br J Radiol. 2023 Mar 1;96(1144):20220720. doi: 10.1259/bjr.20220720. Epub 2023 Jan 23. Br J Radiol. 2023. PMID: 36633335 Free PMC article.
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer.
Uchinami Y, Kanehira T, Fujita Y, Miyamoto N, Yokokawa K, Koizumi F, Shido M, Takahashi S, Otsuka M, Yasuda K, Taguchi H, Nakazato K, Kobashi K, Katoh N, Aoyama H. Uchinami Y, et al. Among authors: kobashi k. Clin Transl Radiat Oncol. 2023 Jan 7;39:100576. doi: 10.1016/j.ctro.2023.100576. eCollection 2023 Mar. Clin Transl Radiat Oncol. 2023. PMID: 36686564 Free PMC article.
Predicting the daily gastrointestinal doses of stereotactic body radiation therapy for pancreatic cancer based on the shortest distance between the tumor and the gastrointestinal tract using daily computed tomography images.
Uchinami Y, Kanehira T, Nakazato K, Fujita Y, Koizumi F, Takahashi S, Otsuka M, Yasuda K, Taguchi H, Nishioka K, Miyamoto N, Yokokawa K, Suzuki R, Kobashi K, Takahashi K, Katoh N, Aoyama H. Uchinami Y, et al. Among authors: kobashi k. BJR Open. 2023 Oct 18;5(1):20230043. doi: 10.1259/bjro.20230043. eCollection 2023. BJR Open. 2023. PMID: 37942491 Free PMC article.
Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y, Yasuda K, Minatogawa H, Uchinami Y, Tsushima N, Suzuki T, Kano S, Mori T, Nishioka K, Kobashi K, Katoh N, Homma A, Aoyama H. Dekura Y, et al. Among authors: kobashi k. J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080. J Radiat Res. 2024. PMID: 37952082 Free PMC article.
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan.
Yasuda K, Uchinami Y, Kano S, Taguchi J, Kawakita D, Kitayama M, Nishioka K, Mori T, Koizumi F, Fujii Y, Shimizu Y, Kobashi K, Yoshimoto S, Nibu KI, Homma A, Aoyama H. Yasuda K, et al. Among authors: kobashi k. Int J Clin Oncol. 2024 Mar;29(3):241-247. doi: 10.1007/s10147-023-02450-7. Epub 2023 Dec 29. Int J Clin Oncol. 2024. PMID: 38155239
393 results